Epirubicin/ethiodized-oilTumour lysis syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1897卷 / 1期

关键词：

D O I：

10.1007/s40278-022-11408-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：171 / 171

相关论文

共 50 条

[1] Doxorubicin/ethiodized oilTumour lysis syndrome: 2 case reports
Reactions Weekly, 2010, 1297 (1) : 23 - 23
[2] Cefazolin/doxorubicin/ethiodized oilTumour lysis syndrome and acute renal failure: case report
Reactions Weekly, 2015, 1543 (1) : 60 - 60
[3] Epirubicin/ethiodized oilArteriopathy: case report
Reactions Weekly, 2018, 1685 (1) : 86 - 86
[4] Doxorubicin/ethiodized oilAcute tumour lysis syndrome: case report
Reactions Weekly, 2011, 1343 (1) : 16 - 16
[5] Epirubicin/ethiodized oil/mitomycinMyelosuppression: case report
Reactions Weekly, 2015, 1559 (1) : 70 - 70
[6] Epirubicin/ethiodized-oil/oxaliplatinBiloma: case report
Reactions Weekly, 2020, 1793 (1) : 180 - 180
[7] Epirubicin/ethiodized-oilAcute liver failure: case report
Reactions Weekly, 2020, 1795 (1) : 122 - 122
[8] Epirubicin/ethiodized oil/iopamidolElevated liver enzymes : case report
Reactions Weekly, 2021, 1885 (1) : 207 - 207
[9] Ethiodized oil/iopamidol/mepivacaineKounis syndrome: case report
Reactions Weekly, 2015, 1576 (1) : 132 - 132
[10] Epirubicin/ethiodized oilVarious toxicities: 4 case reports
Reactions Weekly, 2019, 1775 (1) : 194 - 194

← 1 2 3 4 5 →